Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hillevax Inc (HLVX)

Hillevax Inc (HLVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hillevax Inc 321 HARRISON AVE SUITE 500 BOSTON MA 02118 USA

www.hillevax.com P: 617-213-5054

Description:

HilleVax Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 597,646
Enterprise Value, $K 406,206
Shares Outstanding, K 49,721
Annual Sales, $ 0 K
Annual Net Income, $ -123,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -36,960 K
EBIT, $ -133,340 K
EBITDA, $ -133,540 K
60-Month Beta 0.65
% of Insider Shareholders 29.30%
% of Institutional Shareholders 86.42%
Float, K 35,153
% Float 70.70%
Short Volume Ratio 0.71

Growth:

1-Year Return -15.21%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 03/20/24
Latest Earnings Date 05/10/24
Earnings Per Share ttm -3.04
EPS Growth vs. Prev Qtr 3.70%
EPS Growth vs. Prev Year -39.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HLVX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.17%
Return-on-Assets % -38.05%
Profit Margin % 0.00%
Debt/Equity 0.10
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.34
Book Value/Share 5.48
Interest Coverage -50.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar